20 Strategy for Pooled Procurement of Essential Medicines and Health Commodities, 2013-2017 10.2 Outcome and impact evaluation The SADC Secretariat will facilitate an external mid-term review for 2015 and an end-term evaluation for 2017. Both reviews will provide feedback on the efficiency, effectiveness and relevance of the Strategy in achieving the strategic objectives. The report of findings and recommendations of the mid-term review will be widely shared with all stakeholders and shall be used to modify outputs, as necessary. The outcome of the end-term evaluation will be used to design and inform future interventions. The SADC Secretariat will work closely with Members States and key partners to ensure continuous collection and analysis of data in order to facilitate M&E as described above. At national level, access to data on essential medicines and health commodities from sources such as central medical stores and health care facilities will be facilitated by Heads of Pharmaceutical Services with support from a assigned personnel who are conversant with M&E. 11. RESOURCE MOBILISATION The key to successful implementation of this Strategy is the availability of financial, technical and human resources. Limited technical assistance may be required in the form of intermittent technical support or secondment of staff from Member States when required. Initial support for the establishment of the SPPS, and the work and information sharing platforms shall come from Member States, the AfDB-funded Communicable Disease Project and the UKAID-funded Southern African Regional Programme on Access to Medicines and Diagnostics project. At the national level, Member States will be urged to increase budgetary allocations for pooled procurement. These funds will be used to both purchase medicines through this Strategy, as well as pay the agreed fees to the SPPS for managing the services. This will ensure sustainability and ownership of the services. The SADC Secretariat will make available financial resources to monitor and evaluate the Strategy.